Study of AZD2811 + Durvalumab in ES-SCLC

Clinical trial NCT04745689 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04745689
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Small-Cell Lung Cancer

Start date: 2021-02-23
Primary completion: 2022-06-18
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.